SCHEMBL7960467

SCHEMBL7960467

O=C(O)COc1cccc2c1ccn2CCOCCC(c1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 4/20 0.53
PPARG P37231 3/20 0.46
PPARA Q07869 3/20 0.46
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
BAD Q92934 1/20 0.43
HRH2 P25021 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PTGIR P43119 2/20 0.41
TBXA2R P21731 1/20 0.41
RAB9A P51151 1/20 0.40
BCL2 P10415 1/20 0.40
HTR6 P50406 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958447 0.90 MCL1 (0.54) MCL1PPARGPPARANR1H2NR1H3
SCHEMBL7956906 0.88 MCL1 (0.59) MCL1PPARGPPARANR1H2NR1H3
SCHEMBL7948387 0.84 MCL1 (0.55) MCL1PPARGPPARAKDM4EALDH1A1
SCHEMBL7948724 0.84 MCL1 (0.55) MCL1PPARGPPARANR1H2NR1H3
SCHEMBL7958296 0.83 MCL1 (0.56) MCL1PPARGPPARAKDM4EALDH1A1
SCHEMBL7962718 0.80 HTR2C (0.49) MCL1BADMEN1KMT2AHTR6
SCHEMBL7956741 0.79 MCL1 (0.52) MCL1PPARGPPARAKDM4EALDH1A1
SCHEMBL7959753 0.79 PTGIR (0.54) MCL1PPARGPPARANR1H2NR1H3
SCHEMBL7959506 0.79 MCL1 (0.60) MCL1PPARGPPARAKDM4EALDH1A1
SCHEMBL7960155 0.78 MCL1 (0.59) MCL1PPARGPPARAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6323235-B1 CARDIOVASCULAR DISORDERS, ANTIISCHEMIC AGENTS AND ENZYME INHIBITORS OHTAKE ATSUSHI (JP) 2001-11-27 US disclosed
US-6043264-A A THROMBOXANE A2 RECEPTOR ANTAGONIST FOR TREATING HYPERTENSION, THROMBOSIS, ISCHEMIC HEART DISEASES, CIRCULATORY DISEASES, ARTERIOSCLEROSIS, PLATELET FUNCTION DISORDER, HYPERLIPIDEMIA, NEPHRITIS OR ASTHMA TORAY INDUSTRIES, INC. (JP) 2000-03-28 US disclosed
EP-0751126-A1 BENZENE-FUSED HETEROCYCLIC DERIVATIVE AND USE OF THE SAME TORAY INDUSTRIES, INC. (JP) 1997-01-02 EP disclosed